News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Should be sooner than later!
He should start the Top Pepperoni diet...
Sulfites and sulfates hinder investment judgement...
PEPPERONI or MMTC??!
Both are dead, but PEPPERONI tastes way better!!!
Big fat lady stopped singing years ago!!!
It's coming!
California company register confirms MMTC is DEAD!!!
No pal, will you still be here when this is current in a few weeks or any day now?
Pepperoni overdose at work again
MMTC IS DEAD!
I remember reading an article years ago written by the FDA in which they reviewed the MIT and stated if certain kinks in the system such as false positives could be rectified the technology would be welcomed by the food pathogen community. There is no doubt the technology is valuable, I think this time around MMTC will rectify the issues. The tech is NOT obsolete like some will have you believe. I can't wait to see the new direction of the company.
Authorized Shares
100,000,000
06/22/2023
Outstanding Shares
37,071,294
06/22/2023
Restricted
27,019,274
06/22/2023
Unrestricted
10,052,020
06/22/2023
Yet another article about how lasers are the future of food pathogen detection.....
https://www.sciencedirect.com/science/article/abs/pii/S0924224421005987
Purdue used to work with the MMTC team, it was quite impressive. Lasers are the future of food pathogen detection. Interesting article below about Purdue. The MIT however trumps Purdue's Bardot machine.
New technology for pathogen detection driven by lasers
by Chris Adam, Purdue University
Purdue innovators have developed a lanthanide-based assay coupled with a laser that can be used to detect toxins and pathogenic E. coli in food samples, water and a variety of industrial materials. Credit: Purdue University
Researchers at Purdue University have been working to develop new technologies to help stop the spread of foodborne illnesses, which kill 3,000 people a year, by detecting them more efficiently. They have developed a lanthanide-based assay coupled with a laser that can be used to detect toxins and pathogenic E. coli in food samples, water and a variety of industrial materials.
The two key features of the new technology are the incorporation of lanthanides and simple lateral flow paper-based assays. The Purdue team created a method for combining different heavy metals that when linked to antibodies can detect multiple agents in a single analysis. The Purdue team's work is published in the January edition of Analytical and Bioanalytical Chemistry.
"Our goal was to incorporate easily detectable elements into a paper-based assay which is low-cost and effective," said J. Paul Robinson, the SVM Professor of Cytomics in Purdue's College of Veterinary Medicine and a professor of biomedical engineering in Purdue's College of Engineering. "Designing a technology that is both low-cost but also accurate and can detect multiple antigens simultaneously was a critical factor in our decision to work on this problem."
"We are very excited about the acceptance of the intellectual property as this will enhance the possibility of finding commercial partners," Robinson said. "The potential for moving this to handheld, field deployable use is something we see in the future."
The group is evaluating the potential for fully portable use that would allow field use in virtually any environment.
The approach uses a high-powered laser pulse to obliterate a sample, while simultaneously collecting the spectral signature of the resultant emission. These signals are then compared with a database that translates the signals into an identification of the toxin or pathogen.
The work presented in this paper shows the proof of principle and is the basis for significant expansion of the studies. What makes the technology effective is the linking of antibodies to different heavy metal tags. This creates a unique fingerprint of atomic signatures that can be used to determine if any particular pathogen of interest in present in a sample.
Insiders still holding all shares tight to the vest, we will be trading soon enough.
I remember talking to Dr. Bhunia from Purdue, he praised the MIT and said it would hold a special niche in the market. This is anything but dead, current soon.
I sold before going expert, MMTC has been working on the MIT this whole time. Technology is great and Nunez will keep the share structure tight.
Look at the A/S, it was recently raised to 100 million. Obviously they are working at becoming current. It will be current sooner than later.
Nitrites in Pepperoni alters his judgement
Better to load on Pepperoni...than DEAD MMTC
